Summit Therapeutics PLC Sponsored ADR Forecast, price target & analysts
$20.01
8.22%
today
Nasdaq,
Feb 28, 08:48 pm CET
Summit Therapeutics PLC Sponsored ADR Target price 2025 - Analyst rating & recommendation
Powered by
Summit Therapeutics PLC Sponsored ADR Classifications & Recommendation:
Buy
100%
Summit Therapeutics PLC Sponsored ADR Price Target
| Target Price | $35.33 |
| Price | $18.49 |
| Potential |
91.09%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Summit Therapeutics PLC Sponsored ADR 2026 .
The average Summit Therapeutics PLC Sponsored ADR target price is $35.33.
This is
91.09%
register free of charge
$44.00
137.97%
register free of charge
$30.00
62.25%
register free of charge
|
|
| A rating was issued by 6 analysts: 6 Analysts recommend Summit Therapeutics PLC Sponsored ADR to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Summit Therapeutics PLC Sponsored ADR stock has an average upside potential 2026 of
91.09%
register free of charge
|
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.31 | -0.43 |
| 68.69% | 38.71% | |
| P/E | negative |
2 Analysts have issued a Summit Therapeutics PLC Sponsored ADR forecast for earnings per share. The average Summit Therapeutics PLC Sponsored ADR <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
$-0.43
Unlock
38.71%
lower
Unlock
$-0.42
35.48%
Unlock
$-0.44
41.94%
Unlock
This results in the following potential growth metrics and future valuations:
Summit Therapeutics PLC Sponsored ADR...
Current Summit Therapeutics PLC Sponsored ADR Upgrades & Downgrades Beta
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citizens Capital Markets | Locked ➜ Locked | Locked | Feb 25 2025 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Feb 25 2025 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Jan 21 2025 |
| Truist Securities | Locked ➜ Locked | Locked | Jan 08 2025 |
| Wells Fargo | Locked ➜ Locked | Locked | Dec 11 2024 |
| Jefferies | Locked ➜ Locked | Locked | Dec 06 2024 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Nov 18 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Citizens Capital Markets: Locked ➜ Locked
|
Feb 25 2025 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Feb 25 2025 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Jan 21 2025 |
|
Locked
Truist Securities: Locked ➜ Locked
|
Jan 08 2025 |
|
Locked
Wells Fargo: Locked ➜ Locked
|
Dec 11 2024 |
|
Locked
Jefferies: Locked ➜ Locked
|
Dec 06 2024 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Nov 18 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
